Sermo Event™ Reports

Tasigna/Gleevec/Sprycel – Evolving Trends in CML

Capture Physician Insights as the News Happens


What are Sermo Event™ Reports?

Sermo Event Reports tap into the Sermo online community to rapidly assess physician reaction to major events impacting the US pharmaceutical market. Reports are in PowerPoint format and include both the poll results and full transcripts of the physician comments. All respondents are verified and credentialed, ensuring they have valid, active licenses to practice medicine in the United States.

What is Sermo?

Sermo is an online community of 110,000 physicians who discuss treatments, exchange insights and collaborate on difficult cases. For the first time, you can access this exclusive community of physicians to capture the latest medical thinking about your products. With Sermo, you gain real-world insights into the diagnostics, devices or drugs that matter to you.

Estimating the impact of ENESTnd trial data.

According to the report, Oncologists find Tasigna front line data convincing and plan to increase its use in this setting post-FDA approval. However, many are still looking for additional endpoints before making a final judgment. Interestingly, there is not much familiarity of Tasigna front line data in the physician community, even among those who attended ASH 2009.

See the full-results | Contact us to learn more about buying this report.